Can Rivos Challenge Nvidia's Dominance in AI Chips?

Rivos is asking for a lot of money before it has sold a single chip. The Santa Clara startup is reported to be seeking up to $400–500 million in new funding: a raise that would push its lifetime capital close to $900 million and value the business at north of $2 billion. That simple fact explains why this is a story worth watching: investors are being asked to back a product that exists today mostly on paper and in prototype form.

There’s logic to the ask. Rivos designs inference hardware, the kind of compute used to run trained AI models in production, and the company argues there’s room for alternatives to Nvidia’s expensive top-tier cards. CEO Puneet Kumar has said Rivos will aim for “smaller installations where Nvidia might seem like an overkill from a cost perspective.” As model deployment spreads, some customers will prioritize cost, power efficiency and simpler deployments over absolute peak performance.

An opening in Nvidia’s shadow

Nvidia’s dominance rests not only on silicon but on software and habit. CUDA, the company’s developer ecosystem, is deeply embedded in training and deployment pipelines; that’s the practical barrier any rival has to clear. Rivos is trying to lower that barrier. It’s building compatibility tools that aim to let existing CUDA-based models run with less rework, and it’s pairing that software pitch with a hardware strategy based on the open RISC-V architecture.

Those two choices, a migration-friendly software story and a RISC-V cost/licensing angle, are sensible if the goal is to win customers who want “good enough” inference at a far better total cost of ownership. They also mirror moves by other challengers in the market. Companies such as Cerebras, Groq and Positron have all staked different claims: wafer-scale performance, low-latency inference, or rapid, air-cooled deployments. Each has real customers and proven deployments; Rivos does not yet. The difference matters.

Rivos has made progress on the hard engineering side: the company delivered a prototype to TSMC for trial production and says it is targeting mass production in the 2026 timeframe. Even so, design milestones and shipping product at scale are different races. The company has raised earlier rounds (including a reported $250 million Series A-3) and now staffs hundreds of engineers, but moving from a taped-out design to widely available silicon typically requires additional capital, supply-chain work and sales momentum.

There’s also been turbulence. Rivos settled litigation with Apple in early 2024 after a dispute over hiring and alleged trade secrets, a distraction that reportedly complicated fundraising and led to layoffs. That episode is a reminder that execution risk isn’t just technical; it can be legal and organizational too.

A sober read of Rivos’ chances

Rivos is pursuing a plausible niche, but it faces a narrow path. The market opportunity for more efficient inference hardware is real: many enterprises and smaller cloud operators will prefer cheaper, simpler options where appropriate, and geopolitical and supply shifts have opened windows for challengers.

But plausibility is not parity. Breaking the habits of software stacks, proving reliability at scale, and matching the ecosystem convenience buyers expect are tall orders. Competitors that already ship hardware have the advantage of live telemetry, customer references and iterative product lessons. Rivos must translate its prototype and software promise into repeated customer wins before hyperscalers and incumbents consolidate the same edge it seeks.

That reality doesn’t make the raise unreasonable. Chip startups are capital-intensive by design; many require hundreds of millions before volume revenue arrives. What matters is discipline: investors should be buying an execution plan, not just a slide deck. For Rivos, that means clear evidence of software compatibility working with common workloads, firm foundry commitments that reduce manufacturing risk, and early customers willing to put hardware into production.

If Rivos can show those things, its bet: that a sizable slice of the inference market will prefer lower-cost, RISC-V-based alternatives is defensible. If it cannot, the company will be another instructive example of how expensive and unforgiving the path to compete with entrenched infrastructure can be. Either way, this is a test of discipline and the old-fashioned work of building product and customers before the money runs out.